Skip to main content
African Health Sciences logoLink to African Health Sciences
. 2018 Jun;18(2):253–259. doi: 10.4314/ahs.v18i2.8

Quinine inhibits ovulation and produces oxidative stress in the ovary of cyclic Sprague-Dawley rats

Stella Chinwe Gbotolorun 1, Oghenevwakpeje Inikori 1, Olawande Damilola Bamisi 1, Abraham Adewale Adepoju Osinubi 1, Abayomi Olugbenga Okanlawon 1
PMCID: PMC6306975  PMID: 30602950

Abstract

Background

Quinine has been reported to possess anti-spermatogenic activities.

Objectives

This study was carried out to determine the effect of quinine on ovarian function in Sprague-Dawley rats.

Methods

Twenty rats with regular 4-days oestrous cycle divided into 4 groups (N=5) were used. Group I received quinine at 30 mg/kg body weight by gavage for 28 days after which they were sacrificed. The ovaries were excised for biochemical oxidation of glutathione peroxidase (GSH), superoxide dismutase (SOD), catalase and malondialdehyde (MDA). Group II received single dose quinine at 30 mg/kg body weight at 0900 hrs on day of proestrus. Blood was obtained at 1800 hrs for hormonal assay of FSH and LH. The animals were sacrificed the next morning on estrus: oviducts were examined for ova count. Groups III and IV served as controls.

Results

Quinine treated rats recorded zero number of ova compared to control. Serum concentration of LH reduced significantly in the quinine treated group compared to the control. Furthermore, quinine significantly decreased the oxidant status of GSH, SOD and catalase and significantly increased MDA levels in the ovary compared to the control group.

Conclusion

Quinine completely blocks ovulation, suppresses LH surge, and produces oxidative stress in the ovary.

Keywords: Quinine, ovary, LH, ovulation, oxidative stress

Introduction

Quinine is a cinchona alkaloid that belongs to the aryl amino alcohol group of drugs. Almost 400 years after Jesuit priests first documented its efficacy; quinine still remains a therapeutic anti-malarial drug as seen on the WHO Model List of Essential Medicines1. Quinine is still a potent drug in the treatment of the four species of malaria parasites, and is still the treatment of choice for cerebral malaria2 and nocturnal leg cramp3.

Increased production of reactive oxygen species (ROS) in the whole blood has been observed in patients with acute falciparum malaria4 and also in P. vinckei infected mice5. The administration of quinine to non-malarious individuals elicited a flux in erythrocyte lipid peroxidation; with an initial increase followed by a reduction in lipid peroxidation6. Quinine has been reported to generate ROS when photosensitized in the presence of UV-B radiation even within a cellular environment7.

Most of the in-vivo and in-vitro studies to determine the effect of quinine on the reproductive system and function have been carried out on males. The reports from some of these studies using animal models have shown that quinine possesses anti-spermatogenic activities: disrupts spermatogenesis, reduces sperm motility, morphology and sperm count and is deleterious to testicular histoarchitecture810.

There is a dearth of literature on the effect of quinine on the female reproductive system. This study was carried out to determine the effect of quinine on ovarian function in cyclic Sprague-Dawley rats.

Materials and methods

Animals

A total of thirty regular 4-day cycling female rats of Sprague-Dawley strain weighing between 120 – 200 g were used. The animals had access to food and water ad libitum. They were maintained at 25 ± 3°C with photoperiodicity of 12: 12 light: darkness. The animals were observed for clinical signs of drug toxicity throughout the duration of the experiment. All procedures involving animals in this study were approved by the Departmental Committee on the use and care of animals and tissue collection.

Quinine

Quinine dihydrochloride injection, a product of Jiangsu, China, was given intramuscularly at a single dose of 30 mg/kg/day on the morning of proestrus to determine ovulation. To determine oxidative stress, quinine sulphate tablet a product of Wockhart was constituted into a solution by the addition of distilled water and administered at the same dose orally by gavage once daily for 28 days. Our choice of dosage selection was based on a previous study8. This dose falls within the no-effect level and is therefore grossly non-toxic11. Control animals received 1 ml of distilled water.

Determination of ovulation

Ovulation studies were determined using the method of Kim et al12. Briefly, vaginal smear was taken daily to determine the stage of the oestrous cycle. Rats with a preponderance of uniformly nucleated cells indicating the proestrus phase, received a single dose of quinine intramuscularly at 9 a.m. Later the same day in the evening at 6 p.m, blood was collected via ocular puncture using a capillary tube and was stored in heparinized bottles. The next day, which was the day of estrus, the rats were sacrificed by cervical dislocation at 10 a.m. A ventral laparotomy was performed and the oviduct was excised, placed on glass slides with a drop of saline and covered with cover slips. It was squeezed with both sides being gently rocked. Any ovum found in the distended ampulla was counted under a light microscope.

Hormonal assay

Blood was centrifuged and serum was decanted from the plasma and assayed in batches with control sera at both physiological and pathological levels with a microwell kit to determine FSH and LH concentrations.

Oxidative stress study

Quinine was administered daily for 28 days by gavage13. At the end of the treatment period, the rats were sacrificed by cervical dislocation. A ventral laparotomy was performed and the ovaries were excised and kept frozen at −20°C until the day of assay for biochemical analysis of oxidative stress.

Preparation of ovarian tissues for oxidative stress

The ovarian tissue was homogenized in a Teflon-glasshomogenizer with a buffer containing 1.5% potassium chloride to obtain 1:10 (w/v) whole homogenate. MDA was measured using the method described by Farombi et al14. The GSH level in ovarian tissue was estimated as described by Rukkumani et al15. Catalase was assayed colorimetrically at 620 nm and expressed as _mol of H2O2 consumed/min as described by Rukkumani et al15. Total SOD activity was measured by the method described by Sun et al16.

Statistical analysis

Results were analyzed and expressed as mean ± standard error of mean (Mean ± SEM) and subjected to statistical analysis using paired sample t-test. Statistical significance was considered at p< 0.05.

Results

Effect on body weight and ovulation

Control rats gained weight in the course of the treatment and the gain in weight was significantly different at the end of the study. On the other hand the weight of the quinine treated rats reduced significantly by the end of the treatment (Table 1).

Table 1.

Effect of administration of quinine on body weight and on ovulation in cyclic Sprague-Dawley rats

Treatment groups Before (g) After (g) No. of ova shed in the oviduct
Control 162.4 ± 5.2 187 ± 4.6 7.6 ± 0.5
Quinine 185.2 ± 4.0 157.8 ± 6.8* 0.0 ± 0.0*

Values are expressed as mean ± S.E.M (N=5).

*

p<0.05 vs. control.

In addition, quinine completely blocked ovulation as no ovum was observed in the oviduct in the morning of estrus. However, control animals recorded a count of 7.6 ± 0.5 numbers of ova.

Effect on serum concentrations of FSH and LH

Serum concentrations of both FSH and LH (p<0.05) decreased when treated group was compared to the control values (Table 2).

Table 2.

Effect of administration of quinine on serum levels of FSH and LH in cyclic Sprague-Dawley rats

Treatment groups FSH (µlU/ml) LH (µlU/ml)
Control 0.47 ± 0.07 1.17 ± 0.13
Quinine 0.38 ± 0.07 0.81 ± 0.05*

Values are expressed as mean ± S.E.M (N=5).

*

p<0.05 vs. control.

Effect on markers of oxidative stress

The study showed that MDA increased significantly while GSH, Catalase and SOD activities reduced significantly when compared to the control group (Table 3).

Table 3.

Effect of administration of quinine on biochemical oxidation of MDA, GSH, catalase and SOD in cyclic Sprague-Dawley rats

TREATMENT
GROUPS
MDA
(µmole/ml/mg)
GSH
(µmole/ml/mg)
CATALASE
(µmole/ml/min/
mg pro)
SOD
(µmole/ml/min/mg
pro)
Control 2.63 ± 0.07 30.06 ± 0.40 12.78 ± 0.17 2.38 ± 0.35
Quinine 4.39 ± 0.04* 18.39 ± 0.53* 10.44 ± 0.53* 2.09 ± 0.08*

Values are expressed as mean ± S.E.M (N=5).

*

p<0.05 vs. control.

Discussion

Body weight decreased significantly in the quinine treated rats compared to the control rats in this study. This result is consistent with another study in which mice were fed quinine diet. The authors suggested that quinine diet caused weight loss in the mice as a result of de-regulation in intestinal nutrient absorption rather than energy expenditure17.

Numerous animal and human studies have demonstrated the presence of ROS in the female reproductive tract such as in the ovaries1820, the fallopian tubes21 and in embryos22. ROS is involved in the modulation of an entire spectrum of physiological reproductive functions such as oocyte maturation, ovarian steroidogenesis, corpus luteal function and luteolysis1820,23. In the reproductive tract, increased ROS generation is limited by a variety of anti-oxidant enzymes, such as SOD, catalase, and various peroxidases. A delicate balance exists between ROS and anti-oxidant enzymes in the ovaries. Anti-oxidant enzymes neutralize ROS production and protect the oocyte and embryo from apoptosis resulting from nucleic acid strand breaks, lipid peroxidation, protein degradation and ultimately, cell death24. SOD causes a dismutation of superoxide radicals to H2O2, which is further detoxified to water and oxygen by catalase or GSH.

Results from this study revealed that administration of quinine significantly elevated the level of MDA, and at the same time significantly reduced the levels of GSH, SOD and Catalase in the rat ovaries when compared to the control. The report of this study is in agreement with Osinubi et al.,25 who reported that quinine significantly increased levels of MDA in the testes. Also, in another study using amodiaquine, it was reported that amodiaquine caused a significant reduction in the enzymatic anti-oxidant activities of SOD and catalase in the ovaries of Sprague-Dawley rats13. An imbalance between ROS production and anti-oxidants results in oxidative stress. From the result of this study, it can be deduced therefore that the ovaries were under oxidative stress.

Certain drugs acting at various levels of the hypothalamic-pituitary-ovarian axis have been reported to impair ovulation and ultimately, fertility26. Ovulation is the accomplishment of a series of events orchestrated by the surge of LH. These events are characterized by resumption of meiosis, break down of germinal vesicle, granulosa luteinization, stigma formation and ultimately the release of a mature ovum27. In this study, the administration of quinine at 0900 hrs on the morning of proestrus blocked ovulation completely as not a single ovum was found in the oviduct compared to the control. The result of this study is in concert with other investigators who reported a complete block in ovulation with regression of LH surge when chloroquine was administered between 0900 and 1000 hrs on proestrus28,29. No significant difference was observed in the serum concentration of FSH however LH levels decreased significantly from control values. It is a well-established fact that on the afternoon of proestrus, about 2 to 3 p.m., the circulating levels of LH begins to increase rapidly and ultimately reach peak levels by 5 to 7 p.m. on that same evening. This proestrus surge of LH is responsible for the process of and events following ovulation. This surge of LH actuates follicular rupture and the resultant ovulation on the morning of estrus30. The significantly reduced levels of LH observed in this study revealed that the expected surge in LH that induces follicular rupture and eventual ovulation was suppressed.

As shown in our study above, quinine produces overproduction of ROS a fact suggested by the significantly increased levels of MDA an important lipid peroxidation marker. ROS represents the most important class of free radicals generated in living systems. ROS is generated in the form of hydrogen peroxide (H2O2), superoxide radical (O2•−), and hydroxyl radical (OH•). H2O2 is a weak oxidizing agent that can cross rapidly inside the cell membranes and damage intracellular systems31. Removal and neutralization of H2O2 by catalase and glutathione peroxidase is very important for the protection of living systems. Hydrogen peroxide is constantly produced in cells and has been implicated in several ovulation-related events such as steroid hormone production32,33. It has been shown that the addition of hydrogen peroxide to a culture of human chorionic gonadotropin-stimulated luteal cells resulted in reduction of both progesterone and estradiol production20. Estrogens and progesterone are important in the normal functioning of the female reproductive system. The balance in hormonal interplay between estrogens and progesterone is responsible for a normal regular cycle34,35. Several authors have demonstrated that progesterone secreted during the diestrus phase intensifies the negative feedback of estradiol on basal LH secretion and when the level of progesterone falls at luteal regression, estradiol and LH levels rise and ovulation occurs within the following 6–8 h3639. Also, low levels of estrogen inhibit ovulation by delaying the estrogen triggering of LH surge.

Although, progesterone and estrogen levels were not determined in this study however, it may be inferred that the oxidative stress produced by the administration of quinine may have suppressed the production of progesterone and estrogen. The suppressed levels of progesterone and estrogen may have inhibited the threshold of the neural and/or hypophyseal mechanisms responsible for ovulatory LH release leading to a complete block in ovulation in the morning of estrus. Although the dose given in this study falls below the recommended therapeutic dose in humans6,40 however, it is too early to begin to extrapolate the findings of this study to humans. Further studies should be carried out to elucidate the exact mechanism of action by which quinine blocks ovulation and induces oxidative stress in rats. Howbeit, quinine should be taken with caution in women who are undergoing treatment for infertility.

Conclusion

The study demonstrated that quinine suppressed LH surge, completely blocked ovulation and produced oxidative stress in Sprague-Dawley rats.

Recommendation

We have attempted to demonstrate an oxidative stress pathway by which quinine blocks ovulation however; our study was limited because we failed to determine the levels of progesterone and estrogen. Further studies to determine progesterone and estrogen levels should be carried out in order to substantiate and or validate our findings.

Conflict of interest

Authors disclose no conflict of interest.

References

  • 1.WHO, author. 19th World Health Organization Model List of Essential Medicines: April 2015. Geneva: WHO; 2015. [Google Scholar]
  • 2.Ogutu BR, Nzila AM, Ochong E, Mithwani S, Wamola B, Olola CHO, et al. The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. Trop Med Int Health. 2005;5:484–488. doi: 10.1111/j.1365-3156.2005.01415.x. PubMed. [DOI] [PubMed] [Google Scholar]
  • 3.Woodfield R, Goodyear-Smith F, Arroll B. N-of-1 trials of quinine efficacy in skeletal muscle cramps of the leg. Br J Gen Pract. 2005;55:181–185. [PMC free article] [PubMed] [Google Scholar]
  • 4.Descamps-Latscha B, Lunel-Fabiani F, Kara-Binis A, Druilhe P. Generation of reactive oxygen species in whole blood from patients with acute malaria. Parasitol Immunol. 1987;9:275–279. doi: 10.1111/j.1365-3024.1987.tb00507.x. PubMed. [DOI] [PubMed] [Google Scholar]
  • 5.Stoker R, Hunt NH, Clark IA, Weidemann MJ. Production of luminal-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun. 1984;45:708–712. doi: 10.1128/iai.45.3.708-712.1984. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Chikezie PC, Uwakwe AA. Membrane lipid peroxidation of HbAA erythrocyte of non-malarious participants administered with quinine. Free radicals and antioxidants. 2011;2:21–25. [Google Scholar]
  • 7.Yadav N, Dwivedi A, Mujtaba SF, Pal MK, Singh J, Ray RS. Photo-damage to keratinocytes by quinine photosensitization under mild Ultraviolet-B exposure. G- J Environ Sci and Technol. 2014;1:123–128. [Google Scholar]
  • 8.Osinubi AA, Akinlua JT, Agbaje MA, Noronha CC, Okanlawon AO. Effects of short-term administration of quinine on the seminiferous tubules of Sprague-Dawley rats. Nig J Health Biomed Sci. 2004;3:1–7. [Google Scholar]
  • 9.Nwangwa EK, Igweh JC, Uzuegbu UE, Adegor AC. The effects of Quinine therapy on the seminal fluid analysis and histology of testes of male rats. Biosci Biotechnol Res Asia. 2007;4:111–116. [Google Scholar]
  • 10.Ejebe DE, Ojieh AE, Ovuakporaye SI, Odion-Obomhense HK, Adegor EC, Amadi CN, et al. Effects of anti-malarial alkaloids on the sperm properties and blood levels of reproductive hormones of adult men. Afr J Biotechnol. 2008;7:3395–3400. PubMed. [Google Scholar]
  • 11.Colley J, Edmondson J, Heywood R, Street AE, Prentice DE, Singh H, et al. Quinine hydrochloride toxicity to rats in dietary administration over 13 weeks followed by a 6- week withdrawal period Unpublished Report No. CBL/36/82740, from Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. Submitted to WHO by Cadbury Schweppes, Group Research, Reading, England. 1982. [Google Scholar]
  • 12.Kim CY, Wakabayashi K, Nobunaga T. Time-dependent ovulation-blocking effect of ether anesthesia differs from pentobarbital in rats. Tohoku J Exp Med. 1994;172:237–242. doi: 10.1620/tjem.172.237. PubMed. [DOI] [PubMed] [Google Scholar]
  • 13.Gbotolorun SC, Osinubi AAA, Oremosu AA, Noronha CC. The effect of amodiaquine on oestrous cycle, ovarian histology and oxidative stress markers in regular cyclic Sprague-Dawley rats. Agric Biol J N Am. 2011;2:630–637. PubMed. [Google Scholar]
  • 14.Farombi EO, Tahnteng JG, Agboola AO, Nwankwo JO, Emerole GO. Chemoprevention of 2 acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by kolaviron-a Garcinia kola seed extract. Food Chem Toxicol. 2000;38:535–541. doi: 10.1016/s0278-6915(00)00039-9. PubMed. [DOI] [PubMed] [Google Scholar]
  • 15.Rukkumani R, Aruna K, Varma PS, Rajasekaran KN, Menon VP. Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress. J Pharm Pharm Sci. 2004;7:274–283. [PubMed] [Google Scholar]
  • 16.Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1998;34:497–500. PubMed. [PubMed] [Google Scholar]
  • 17.Cettour-Rose P, Bezençon C, Darimont C, le Coutre J, Damak S. Quinine controls body weight gain without affecting food intake in male C57BL6 mice. BMC Physiol. 2013;13:5. doi: 10.1186/1472-6793-13-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sabatini L, Wilson C, Lower A, Al-Shawaf T, Grudzinskas JG. Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization. Fertil Steril. 1999;72:1027–1034. doi: 10.1016/s0015-0282(99)00411-2. PubMed. [DOI] [PubMed] [Google Scholar]
  • 19.Suzuki T, Sugino N, Fukaya T, Sugiyama S, Uda T, Takaya R, et al. Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril. 1999;72:720–726. doi: 10.1016/s0015-0282(99)00332-5. PubMed. [DOI] [PubMed] [Google Scholar]
  • 20.Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig. 2001;8(Suppl 1):40–42. doi: 10.1016/s1071-5576(00)00106-4. [DOI] [PubMed] [Google Scholar]
  • 21.El Mouatassim S, Guerin P, Menezo Y. Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol Hum Reprod. 1999;5:720–725. doi: 10.1093/molehr/5.8.720. PubMed. [DOI] [PubMed] [Google Scholar]
  • 22.Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update. 2001;7:175–189. doi: 10.1093/humupd/7.2.175. PubMed. [DOI] [PubMed] [Google Scholar]
  • 23.Ishikawa M. Oxygen radicals-superoxide dismutase system and reproduction medicine. Nippon Sanka Fujinka Gakkai Zasshi. 1993;45:842–848. [PubMed] [Google Scholar]
  • 24.Yu BP. Cellular defences against damage from reactive oxygen species. Physiol Rev. 1994;74:139–162. doi: 10.1152/physrev.1994.74.1.139. [DOI] [PubMed] [Google Scholar]
  • 25.Osinubi AA, Daramola AO, Noronha CC, Okanlawon AO, Ashiru OA. The effect of quinine and ascorbic acid on rat testes. West Afr J Med. 2007;26:217–221. doi: 10.4314/wajm.v26i3.28313. PubMed. [DOI] [PubMed] [Google Scholar]
  • 26.Astwood EB. Changes in the weight and water content of the uterus of the normal adult rat. Am J Physiol. 1939;126:162–170. [Google Scholar]
  • 27.Lipner H. Mechanism of mammalian ovulation. In: Knobil E, Neill JD, editors. The physiology of Reproduction. New York: Raven Press; 1988. pp. 447–488. [Google Scholar]
  • 28.Okanlawon AO, Ashiru OA. Effect of chloroquine on estrus cycle and ovulation in cyclic rats. J Appl Toxicol. 1992;12:45–48. doi: 10.1002/jat.2550120110. PubMed. [DOI] [PubMed] [Google Scholar]
  • 29.Noronha CC, Osinubi AA, Ashiru OA, Okanlawon AO. The reversal effect of human chorionic gonadotropin on chloroquine inhibition ovulation: evidence for a critical period. J Med and Medical Sci. 2001;3:8–10. [Google Scholar]
  • 30.Freeman ME, Knobil E, Neill JD, editors. The ovarian cycle of the rat. Physiology of Reproduction. New York: Raven Press Ltd.; 1988. pp. 1893–1928. [Google Scholar]
  • 31.Nayana H, Pusparaj S, Anowar H, Sanjib D. Phenolics Content and Antioxidant activity of Crude Extract of Oldenlandia corymbosa and Bryophyllum pinnatum. Res J Pharm Biol Chem Sci. 2012;3:297–303. [Google Scholar]
  • 32.Nakamura Y, Ohtaki S. Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cells. J Endocrinol. 1990;126:283–287. doi: 10.1677/joe.0.1260283. PubMed. [DOI] [PubMed] [Google Scholar]
  • 33.Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol. 2003;5:447–453. doi: 10.1038/ncb981. PubMed. [DOI] [PubMed] [Google Scholar]
  • 34.Leung PC, Armstrong DT. Interactions of steroids and gonadotropins in the control of steroidogenesis in the ovarian follicle. Ann Rev Physiol. 1980;42:71–82. doi: 10.1146/annurev.ph.42.030180.000443. PubMed. [DOI] [PubMed] [Google Scholar]
  • 35.Boubekri A, Gernigon-Spychalowicz T, Khammar F, Exbrayat J-M. Morphometry and immunohistochemistry of follicles growth and steroidogenesis in saharian wild sand rat, Psammomys obesus, ovary. Folia Histochem Cyto. 2009;47:59–66. doi: 10.2478/v10042-009-0055-6. [DOI] [PubMed] [Google Scholar]
  • 36.Beattie CW, Corbin A. The differential effects of diestrous progesterone administration on proestrous gonadotropin levels. Endocrinol. 1975;97:885–980. doi: 10.1210/endo-97-4-885. [DOI] [PubMed] [Google Scholar]
  • 37.Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinol. 1975;96:219–226. doi: 10.1210/endo-96-1-219. PubMed. [DOI] [PubMed] [Google Scholar]
  • 38.Taya K, Terranova PF, Greenwald GS. Acute effects of exogenous progesterone on follicular steroidogenesis in the cyclic rats. Endocrinol. 1981;108:2324–2330. doi: 10.1210/endo-108-6-2324. PubMed. [DOI] [PubMed] [Google Scholar]
  • 39.Kaneko S, Sato N, Sato K, Hashimoto I. Changes in plasma progesterone, estradiol, follicle-stimulating hormone and luteinizing hormone during diestrus and ovulation in rats with 5-day estrous cycles; effect of antibody against progesterone. Biol Reprod. 1986;34:488–494. doi: 10.1095/biolreprod34.3.488. [DOI] [PubMed] [Google Scholar]
  • 40.Bateman DN, Dyson EH. Quinine toxicity. Adv Drug React Ac Pois Rev. 1986;4:215–233. [PubMed] [Google Scholar]

Articles from African Health Sciences are provided here courtesy of Makerere University Medical School

RESOURCES